World Heart Day: San Diego heart surgeon breaks down GLP-1s, cholesterol and lowering surgical risk

Дата публикации: 29-09-2026 16:49:35

SAN DIEGO (KUSI) — Heart disease remains the leading cause of death in the United States, but some of the biggest conversations in heart health are changing — from the growing use of GLP-1 medications to new guidance surrounding cholesterol and a greater focus on reducing a patient’s risk long before they ever enter an [...]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Why cardiovascular disease became the leading cause of death among Hispanic individuals in the US	0	7.84	28-09-2026
2	In the grip of a heart attack: How to recognize the signs and react	0	4.68	21-09-2026
3	Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk	0	9.67	21-05-2026
4	Eli Lilly's Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity	7	8	31-07-2025
5	Popular diabetes drug shown to lower inflammation, which may protect the heart	0	11.73	06-10-2026
6	Combination GLP-1 and SGLT2 therapy may lower heart risk	0	5	25-06-2026
7	6 июля — Всемирный день кардиолога Сердечно‑сосудистые заболевания — одна ...	5	7	06-07-2026
8	Ученые нашли четыре признака старения сердца	0	10.4	21-07-2026
9	GLP-1s may improve outcomes in patients with PAD, diabetes	5	7	08-07-2026
10	Statin guidelines lower treatment age to 30 as bad cholesterol remains linked to 27,000 deaths in Spain	0	15.69	04-08-2026

Классификация: Мнения. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 6.07. Источник: fox5sandiego.com.